Use this button to switch between dark and light mode.

Orphan Drug Exclusivity Recent Developments

September 05, 2023 (2 min read)

Learn about considerations for clinical trial sponsors seeking approval of orphan drugs in light of the exclusivity provisions of the Orphan Drug Act and tension between the interpretation of those provisions by the FDA and the courts.

Read now »


Related Content

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

*Offer is void where prohibited by law or by your employer’s policies. Individual must complete the survey in its entirety and in accordance with all instructions by September 30, 2023, to be eligible for gift card offer. Only one gift card, valued at $25, will be given per individual, while supplies last. Employees of any governmental entity are not eligible to participate in this offer. No returns or exchanges. Offer is valid through September 30, 2023. The questionnaire responses will be reviewed for accuracy and relevancy prior to delivery of the gift card. Other restrictions may apply.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+